Translational studies involving the reuse and association of drugs are approaches that can result in higher success rates in the discovery and development of drugs for serious public health problems, including leishmaniasis. If we consider the number of pathogenic species in relation to therapeutic options, this arsenal is still small, and each drug possesses a disadvantage in terms of toxicity, efficacy, price, or treatment regimen. In the search for new drugs, we performed a drug screening of L. amazonensis promastigotes and intracellular amastigotes of fifty available drugs belonging to several classes according to their pharmacophoric group. Spironolactone, a potassium-sparing diuretic, proved to be the most promising drug candidate. After demonstrating the in vitro antileishmanial activity, we evaluated the efficacy on a murine experimental model with L. amazonensis and L. infantum. The treatment controlled the cutaneous lesion and reduced the parasite burden of L. amazonensis significantly, as effectively as meglumine antimoniate. The treatment of experimental visceral leishmaniasis was effective in reducing the parasite load on the main affected organs (spleen and liver) via high doses of spironolactone. The association between spironolactone and meglumine antimoniate promoted better control of the parasite load in the spleen and liver compared to the group treated with meglumine antimoniate alone. These results reveal a possible benefit of the concomitant use of spironolactone and meglumine antimoniate that should be studied more in depth for the future possibility of repositioning for leishmaniasis co-therapy.
We investigated the effect of extracts of the germinated seeds of yellow soybean cultivar BRS 258 (Glycine max [L.] Merrill) against Leishmania amazonensis promastigotes. The yellow soybean embryos extract (YSEE) was fractionated on a Sephacryl S-100 gel filtration column coupled to AKTA. Then, the fractions were applied on a 1D SDS-PAGE gels and analyzed using a Micromass ESI-Q-ToF mass spectrometer coupled to a NanoUPLC. The anti-Leishmania properties of the soybean and the Jack bean (Canavalia ensiformis) urease were evaluated by measuring promastigotes mitochondrial activity using the MTT method. The YSEE reduced significantly L. amazonensis promastigotes cell viability (94.9%) and this inhibition can be related to an embryo-specific urease. We suggest that this enzyme was able to reduce the cell viability of L. amazonensis, since an anti-Leishmania activity was confirmed with an isolated urease of the legume Jack bean. The results suggest a possible relationship of soybean embryos with urease and leishmanicidal activities. Up to now, no data were found in the literature that demonstrates an anti-Leishmaniaactivity from an embryo-specific urease of soybean.